Jump to content


E-Newsletter Signup Like us on Facebook Sign Up For Our e-Newsletter
Photo

Rytary


  • Please log in to reply
4 replies to this topic

#1 slumpy1

slumpy1

    Newbie

  • Members
  • Pip
  • 2 posts
  • LocationRidgecrest, CA

Posted 07 January 2013 - 08:22 PM

My Neurologist told me about a new form of L-Dopa that's about to be released called Rytary. As you're most likely aware, Rytary is an extended release oral L-DOPA formulation that is comprised of small beads.The beads release L-DOPA slowly as it goes through the small intestine.

Any idea when Rytary will actually be available for PWPs?
Slumpy

#2 Dr. Okun

Dr. Okun

    Advanced Member

  • Ask the Doctor Moderators
  • PipPipPip
  • 4,731 posts
  • LocationUniversity of Florida

Posted 08 January 2013 - 09:23 PM

I will post for you to see if anyone has updated information.
Michael S. Okun, M.D.
Author of the Amazon Bestseller Parkinson's Treatment: 10 Secrets to a Happier Life
National Medical Director | NPF
UF Center for Movement Disorders & Neurorestoration
Read More about Dr. Okun at: http://movementdisor...hael-s-okun-md/
or Visit Parkinson's Disease treatment and research blogs at:
NPF's What's Hot in Parkinson's disease
or his parkinsonsecrets.com blog for treatment tips

#3 miracleseeker

miracleseeker

    Advanced Member

  • Members
  • PipPipPip
  • 989 posts

Posted 09 January 2013 - 03:26 PM

Ah yes this super pill that everyone has been eagerly awaiting. Unfortunately for my mom it won't mean a thing since it sounds like it has to be swallowed whole which she won't.

#4 slumpy1

slumpy1

    Newbie

  • Members
  • Pip
  • 2 posts
  • LocationRidgecrest, CA

Posted 11 January 2013 - 12:20 PM

Found this on Drugs.com:

Oct 12, 2012- Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the Rytary (IPX066) New Drug Application (NDA) from October 21, 2012, to January 21, 2013.

About Rytary

Rytary is an investigational extended release capsule formulation of carbidopa-levodopa for the treatment of idiopathic Parkinson's diseasePosted Image. It is not approved or licensed anywhere in the world. Results from the pivotal phase III studies of IPX066, APEX-PD (early PD), ADVANCE-PD (advanced PD) and ASCEND-PD (advanced PD) have previously been announced
Slumpy

#5 Dr. Okun

Dr. Okun

    Advanced Member

  • Ask the Doctor Moderators
  • PipPipPip
  • 4,731 posts
  • LocationUniversity of Florida

Posted 12 January 2013 - 10:35 AM

This is the extended release dopamine drug NPF has been following and it now has a name Rytary instead of IPX066. The hope is that it will "come on faster" and last a little longer...
Michael S. Okun, M.D.
Author of the Amazon Bestseller Parkinson's Treatment: 10 Secrets to a Happier Life
National Medical Director | NPF
UF Center for Movement Disorders & Neurorestoration
Read More about Dr. Okun at: http://movementdisor...hael-s-okun-md/
or Visit Parkinson's Disease treatment and research blogs at:
NPF's What's Hot in Parkinson's disease
or his parkinsonsecrets.com blog for treatment tips




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users